PT77040A - Process for preparing c-23 modified dmt derivatives - Google Patents

Process for preparing c-23 modified dmt derivatives

Info

Publication number
PT77040A
PT77040A PT77040A PT7704083A PT77040A PT 77040 A PT77040 A PT 77040A PT 77040 A PT77040 A PT 77040A PT 7704083 A PT7704083 A PT 7704083A PT 77040 A PT77040 A PT 77040A
Authority
PT
Portugal
Prior art keywords
optionally substituted
alkanoyl
hydrogen
phenylacetyl
phenylpropionyl
Prior art date
Application number
PT77040A
Other languages
English (en)
Inventor
Herbert Andrew Kirst
John Eldon Toch
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PT77040A publication Critical patent/PT77040A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Saccharide Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrane Compounds (AREA)
  • Liquid Crystal Substances (AREA)
  • Train Traffic Observation, Control, And Security (AREA)
  • Emergency Protection Circuit Devices (AREA)
  • Steroid Compounds (AREA)
PT77040A 1982-07-19 1983-07-18 Process for preparing c-23 modified dmt derivatives PT77040A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/399,656 US4452784A (en) 1982-07-19 1982-07-19 C-23-Modified derivatives of DMT

Publications (1)

Publication Number Publication Date
PT77040A true PT77040A (en) 1983-08-01

Family

ID=23580425

Family Applications (1)

Application Number Title Priority Date Filing Date
PT77040A PT77040A (en) 1982-07-19 1983-07-18 Process for preparing c-23 modified dmt derivatives

Country Status (19)

Country Link
US (1) US4452784A (pt)
EP (1) EP0099746B1 (pt)
JP (1) JPS5931796A (pt)
KR (1) KR850000966B1 (pt)
AT (1) ATE23047T1 (pt)
AU (1) AU1693583A (pt)
CA (1) CA1202964A (pt)
DD (1) DD210059A5 (pt)
DE (1) DE3367104D1 (pt)
DK (1) DK330483D0 (pt)
ES (1) ES8504841A1 (pt)
FI (1) FI832604A (pt)
GB (1) GB2123827B (pt)
GR (1) GR78387B (pt)
NZ (1) NZ204940A (pt)
PH (1) PH19727A (pt)
PL (1) PL243091A1 (pt)
PT (1) PT77040A (pt)
ZA (1) ZA835216B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58219197A (ja) * 1982-06-15 1983-12-20 Sanraku Inc マクロライド系抗生物質の誘導体
US4436729A (en) * 1982-06-30 1984-03-13 Schering Corporation 23-Demycinosyltylosin compounds, pharmaceutical compositions and method of use
US4629786A (en) * 1983-02-28 1986-12-16 Eli Lilly And Company C-20- and C-23 modified macrolide derivatives
US4656258A (en) * 1983-03-03 1987-04-07 Eli Lilly And Company Macrocin derivatives
JPS62103098A (ja) * 1985-05-13 1987-05-13 Microbial Chem Res Found タイロシン誘導体
OA08732A (fr) * 1987-05-06 1989-03-31 Adir Nouveaux dérivés macrolides, leur procédé de préparation et les compositions pharmaceutiques les contenant.

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE667952A (pt) * 1964-08-05
US4358584A (en) * 1979-05-23 1982-11-09 Eli Lilly And Company Antibiotics A6888C and A6888X
JPS56122397A (en) * 1980-02-29 1981-09-25 Satoshi Omura Marcolides
US4321361A (en) * 1980-06-12 1982-03-23 Eli Lilly And Company Demycinosyltylosin and process for its production
ZA813578B (en) * 1980-06-12 1983-01-26 Lilly Co Eli Macrolide antibiotics
US4438109A (en) * 1980-07-25 1984-03-20 Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai Tylosin derivatives
US4304856A (en) * 1980-11-10 1981-12-08 Eli Lilly And Company Process for producing 20-dihydro-20-deoxy-23-demycinosyltylosin
US4341770A (en) * 1981-04-20 1982-07-27 Eli Lilly And Company Method of controlling ureaplasma infections
US4341771A (en) * 1981-04-20 1982-07-27 Eli Lilly And Company Method of controlling Pasteurella infections
AU551142B2 (en) * 1981-07-09 1986-04-17 Zaidan Hojin Biseibutsu Kagaku Kenkyukai Tylosin derivatives
JPS58219197A (ja) * 1982-06-15 1983-12-20 Sanraku Inc マクロライド系抗生物質の誘導体
US4436729A (en) * 1982-06-30 1984-03-13 Schering Corporation 23-Demycinosyltylosin compounds, pharmaceutical compositions and method of use

Also Published As

Publication number Publication date
GB8319306D0 (en) 1983-08-17
KR850000966B1 (ko) 1985-07-02
GB2123827A (en) 1984-02-08
US4452784A (en) 1984-06-05
ZA835216B (en) 1984-03-28
FI832604A0 (fi) 1983-07-18
GB2123827B (en) 1986-07-30
ES524197A0 (es) 1985-05-01
PH19727A (en) 1986-06-17
EP0099746A1 (en) 1984-02-01
PL243091A1 (en) 1984-07-16
FI832604A (fi) 1984-01-20
DE3367104D1 (en) 1986-11-27
NZ204940A (en) 1985-11-08
DD210059A5 (de) 1984-05-30
JPS5931796A (ja) 1984-02-20
DK330483D0 (da) 1983-07-18
ES8504841A1 (es) 1985-05-01
KR840005462A (ko) 1984-11-12
CA1202964A (en) 1986-04-08
AU1693583A (en) 1984-01-26
GR78387B (pt) 1984-09-26
EP0099746B1 (en) 1986-10-22
ATE23047T1 (de) 1986-11-15

Similar Documents

Publication Publication Date Title
PT77039A (en) Process for the preparation of 5-o-mycaminesil tylonolide c-23 modified derivatives
PT77040A (en) Process for preparing c-23 modified dmt derivatives
ZA784187B (en) Crystalline form of the sodium salt of an oxime derivative of 7-amino thiazolyl acetamido cephalosporanic acid,process for preparing it and the pharmaceutical compositions containing it
DE3269543D1 (en) Antibiotic derivatives from cephalosporins
JPS568286A (en) Printer control ststem at ribbon end detection
HK52089A (en) 7-beta-(alpha-syn-methoxyimino-alpha-(2-amino-thiazol-4-yl)acetamido)-3-((1,2,3-thiadiazol-5-ylthio)methyl)-3-cephem-4-carboxylic acid and c1-c6 alkyl derivatives thereof
LU79080A1 (fr) Procede de preparation de nouvelles oximes derivees de 1'acide 3-thiadiazolyl thiomethyl 7-amino thiazolyl acetamido cephalosporanique
SE8801945L (sv) Nya 5-metoxi- aklylammonium- tetrahydrofuraner och -tetrahydrotiofener
IL60889A (en) Insulin crystal suspension and process for the preparation thereof
GB1557423A (en) Cephalosporins
JPS53139542A (en) Intermittent fixation method
IE890905L (en) A process for preparing 3-unsubstituted cephalosporins and 1-carba(dethia) cephalosporins
JPS5399943A (en) Drive method for optical system of copier
JPS5615355A (en) Apparatus for preparing facsimile mimeographic stencil paper plate
JPS5535293A (en) Method of exchanging control rod drive mechanism
HUT68686A (en) Optically active cyclohexenone oxime ethers, process and intermediate products for their production and their use as herbicides
ZA785394B (en) A novel process for producing 7-(d(-)-a-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)a-(4-hydroxophenyl)acetamido/-3-/5-(1-methyl-1,2,3,4-tetrazolyl)thiomethyl/-delta3-cephem-4-carboxylic acid and a pharmaceutically acceptable salt thereof and an intermediate thereof and a process for producing the intermediate
JPS52137219A (en) Address control system of buffer memory